Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
Autor(a) principal: | |
---|---|
Data de Publicação: | 2003 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1038/sj.bjp.0705200 http://repositorio.unifesp.br/handle/11600/27215 |
Resumo: | 1 Bradykinin (BK) appears to play an important role in the development and maintenance of inflammation. Here, we assessed the role of the BK B-2 receptor for the injuries that occur after ischemia and reperfusion (I/R) of the territory irrigated by the superior mesenteric artery.2 Tissue (lung and duodenum) kallikrein activity increased after ischemia with greater enhancement after reperfusion. A selective inhibitor of tissue kallikrein, Phenylacetyl-Phe-Ser-Arg-N-(2,3-dinitrophenyl)-ethylenediamine (TKI, 0.001 - 10 mg ml(-1)), inhibited kallikrein activity in a concentration-dependent manner in vitro. in vivo, pretreatment with TKI (30 mg kg(-1)) prevented the extravasation of plasma and the recruitment of neutrophils.3 Similarly, the bradykinin B-2 receptor antagonists, HOE 140 (0.01-1.0 mg kg(-1)) or FR173657 (10.0 mg kg(-1)), inhibited reperfusion-induced increases in vascular permeability and the recruitment of neutrophils in the intestine and lungs.4 in a model of more severe I/R injury, HOE 140 (1.0mg kg(-1)) inhibited the increase in vascular permeability, neutrophil recruitment, haemorrhage and tissue pathology. Furthermore, HOE 140 significantly inhibited the elevations of TNF-alpha in tissue and serum and partially prevented lethality. This was associated with an increase in the concentrations of IL-10 in tissue and serum.5 Thus, our results demonstrate that, following intestinal I/R injury, there is an increase in tissue kallikrein activity and activation of BK B-2 receptors. B-2 receptor activation is essential for the development of inflammatory tissue injury and lethality. These results contrast with those of others showing that BK mostly exerts a protective role during I/R injury. |
id |
UFSP_79e9bec64ed94c67e5d86f473f830582 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/27215 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injuryischemia and reperfusioncytokinesTNF-alphabradykininneutrophilsshock1 Bradykinin (BK) appears to play an important role in the development and maintenance of inflammation. Here, we assessed the role of the BK B-2 receptor for the injuries that occur after ischemia and reperfusion (I/R) of the territory irrigated by the superior mesenteric artery.2 Tissue (lung and duodenum) kallikrein activity increased after ischemia with greater enhancement after reperfusion. A selective inhibitor of tissue kallikrein, Phenylacetyl-Phe-Ser-Arg-N-(2,3-dinitrophenyl)-ethylenediamine (TKI, 0.001 - 10 mg ml(-1)), inhibited kallikrein activity in a concentration-dependent manner in vitro. in vivo, pretreatment with TKI (30 mg kg(-1)) prevented the extravasation of plasma and the recruitment of neutrophils.3 Similarly, the bradykinin B-2 receptor antagonists, HOE 140 (0.01-1.0 mg kg(-1)) or FR173657 (10.0 mg kg(-1)), inhibited reperfusion-induced increases in vascular permeability and the recruitment of neutrophils in the intestine and lungs.4 in a model of more severe I/R injury, HOE 140 (1.0mg kg(-1)) inhibited the increase in vascular permeability, neutrophil recruitment, haemorrhage and tissue pathology. Furthermore, HOE 140 significantly inhibited the elevations of TNF-alpha in tissue and serum and partially prevented lethality. This was associated with an increase in the concentrations of IL-10 in tissue and serum.5 Thus, our results demonstrate that, following intestinal I/R injury, there is an increase in tissue kallikrein activity and activation of BK B-2 receptors. B-2 receptor activation is essential for the development of inflammatory tissue injury and lethality. These results contrast with those of others showing that BK mostly exerts a protective role during I/R injury.Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, BrazilUniv Fed Minas Gerais, Inst Ciencias Biol, Dept Farmacol, Belo Horizonte, MG, BrazilUniv Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, BrazilNatl Inst Biol Stand & Controls, Div Endocrinol, Potters Bar EN6 3QG, Herts, EnglandUniv Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, BrazilWeb of ScienceNature Publishing GroupUniversidade Federal de Minas Gerais (UFMG)Universidade Federal de São Paulo (UNIFESP)Natl Inst Biol Stand & ControlsSouza, Daniele G.Pinho, VanessaPesquero, Jorge L.Lomez, Eliane S.Poole, SteveJuliano, Luiz [UNIFESP]Correa Junior, AryCastro, M Salete DTeixeira, Mauro M.2016-01-24T12:33:48Z2016-01-24T12:33:48Z2003-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion129-139http://dx.doi.org/10.1038/sj.bjp.0705200British Journal of Pharmacology. London: Nature Publishing Group, v. 139, n. 1, p. 129-139, 2003.10.1038/sj.bjp.07052000007-1188http://repositorio.unifesp.br/handle/11600/27215WOS:000183125500015engBritish Journal of Pharmacologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:33:48Zoai:repositorio.unifesp.br/:11600/27215Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:33:48Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury |
title |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury |
spellingShingle |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury Souza, Daniele G. ischemia and reperfusion cytokines TNF-alpha bradykinin neutrophils shock |
title_short |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury |
title_full |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury |
title_fullStr |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury |
title_full_unstemmed |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury |
title_sort |
Role of the bradykinin B-2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury |
author |
Souza, Daniele G. |
author_facet |
Souza, Daniele G. Pinho, Vanessa Pesquero, Jorge L. Lomez, Eliane S. Poole, Steve Juliano, Luiz [UNIFESP] Correa Junior, Ary Castro, M Salete D Teixeira, Mauro M. |
author_role |
author |
author2 |
Pinho, Vanessa Pesquero, Jorge L. Lomez, Eliane S. Poole, Steve Juliano, Luiz [UNIFESP] Correa Junior, Ary Castro, M Salete D Teixeira, Mauro M. |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de Minas Gerais (UFMG) Universidade Federal de São Paulo (UNIFESP) Natl Inst Biol Stand & Controls |
dc.contributor.author.fl_str_mv |
Souza, Daniele G. Pinho, Vanessa Pesquero, Jorge L. Lomez, Eliane S. Poole, Steve Juliano, Luiz [UNIFESP] Correa Junior, Ary Castro, M Salete D Teixeira, Mauro M. |
dc.subject.por.fl_str_mv |
ischemia and reperfusion cytokines TNF-alpha bradykinin neutrophils shock |
topic |
ischemia and reperfusion cytokines TNF-alpha bradykinin neutrophils shock |
description |
1 Bradykinin (BK) appears to play an important role in the development and maintenance of inflammation. Here, we assessed the role of the BK B-2 receptor for the injuries that occur after ischemia and reperfusion (I/R) of the territory irrigated by the superior mesenteric artery.2 Tissue (lung and duodenum) kallikrein activity increased after ischemia with greater enhancement after reperfusion. A selective inhibitor of tissue kallikrein, Phenylacetyl-Phe-Ser-Arg-N-(2,3-dinitrophenyl)-ethylenediamine (TKI, 0.001 - 10 mg ml(-1)), inhibited kallikrein activity in a concentration-dependent manner in vitro. in vivo, pretreatment with TKI (30 mg kg(-1)) prevented the extravasation of plasma and the recruitment of neutrophils.3 Similarly, the bradykinin B-2 receptor antagonists, HOE 140 (0.01-1.0 mg kg(-1)) or FR173657 (10.0 mg kg(-1)), inhibited reperfusion-induced increases in vascular permeability and the recruitment of neutrophils in the intestine and lungs.4 in a model of more severe I/R injury, HOE 140 (1.0mg kg(-1)) inhibited the increase in vascular permeability, neutrophil recruitment, haemorrhage and tissue pathology. Furthermore, HOE 140 significantly inhibited the elevations of TNF-alpha in tissue and serum and partially prevented lethality. This was associated with an increase in the concentrations of IL-10 in tissue and serum.5 Thus, our results demonstrate that, following intestinal I/R injury, there is an increase in tissue kallikrein activity and activation of BK B-2 receptors. B-2 receptor activation is essential for the development of inflammatory tissue injury and lethality. These results contrast with those of others showing that BK mostly exerts a protective role during I/R injury. |
publishDate |
2003 |
dc.date.none.fl_str_mv |
2003-05-01 2016-01-24T12:33:48Z 2016-01-24T12:33:48Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1038/sj.bjp.0705200 British Journal of Pharmacology. London: Nature Publishing Group, v. 139, n. 1, p. 129-139, 2003. 10.1038/sj.bjp.0705200 0007-1188 http://repositorio.unifesp.br/handle/11600/27215 WOS:000183125500015 |
url |
http://dx.doi.org/10.1038/sj.bjp.0705200 http://repositorio.unifesp.br/handle/11600/27215 |
identifier_str_mv |
British Journal of Pharmacology. London: Nature Publishing Group, v. 139, n. 1, p. 129-139, 2003. 10.1038/sj.bjp.0705200 0007-1188 WOS:000183125500015 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
British Journal of Pharmacology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
129-139 |
dc.publisher.none.fl_str_mv |
Nature Publishing Group |
publisher.none.fl_str_mv |
Nature Publishing Group |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268384654655488 |